Andrew Chan Selected Research

Anticonvulsants (Antiepileptic Drugs)

1/2014	Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.
1/2011	Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Chan Research Topics

Disease

82	Multiple Sclerosis 03/2024 - 02/2006
13	Relapsing-Remitting Multiple Sclerosis 01/2022 - 03/2015
12	Infections 01/2024 - 12/2003
11	Progressive Multifocal Leukoencephalopathy 01/2017 - 12/2008
10	Neoplasms (Cancer) 09/2023 - 06/2004
9	COVID-19 01/2024 - 10/2020
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2023 - 01/2007
6	Neuromyelitis Optica (Devic's Disease) 01/2023 - 03/2013
6	Neuroinflammatory Diseases 01/2022 - 01/2007
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2009
5	Disease Progression 01/2023 - 09/2014
5	Pain (Aches) 11/2022 - 09/2014
5	Chronic Progressive Multiple Sclerosis 01/2021 - 09/2007
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 04/2011
4	Scoliosis 02/2022 - 11/2012
4	Neurocognitive Disorders (Clerambault Syndrome) 02/2019 - 11/2014
4	Drug-Related Side Effects and Adverse Reactions 12/2015 - 12/2003
3	Atrophy 01/2024 - 12/2013
3	Hemorrhage 09/2023 - 11/2020
3	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 06/2012
3	Stroke (Strokes) 11/2022 - 01/2019
3	Optic Neuritis (Retrobulbar Neuritis) 01/2021 - 07/2015
3	Inflammation (Inflammations) 10/2020 - 09/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2019 - 11/2008
2	Body Weight (Weight, Body) 10/2023 - 07/2015
2	Leukocytosis (Pleocytosis) 01/2023 - 11/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 01/2011
2	Adenocarcinoma 10/2022 - 11/2019
2	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 11/2019
2	Ischemic Stroke 01/2022 - 01/2019
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2019
2	Encephalomyelitis (Myeloencephalitis) 01/2021 - 08/2015
2	Neutropenia 11/2020 - 07/2015
2	Colorectal Neoplasms (Colorectal Cancer) 06/2015 - 10/2013
2	Cardiotoxicity 10/2014 - 04/2013
2	Leukemia 08/2014 - 04/2013
2	Seizures (Absence Seizure) 01/2014 - 01/2011
2	Huntington Disease (Huntington's Disease) 05/2011 - 04/2010
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2011 - 03/2008

Drug/Important Bio-Agent (IBA)

15	Natalizumab (Tysabri)FDA Link 01/2017 - 05/2008
11	Immunoglobulin G (IgG)IBA 10/2023 - 06/2012
10	Dimethyl FumarateIBA 01/2023 - 09/2014
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2008
8	AntibodiesIBA 01/2023 - 07/2012
7	Monoclonal AntibodiesIBA 01/2024 - 05/2008
7	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020 - 08/2011
6	GlucocorticoidsIBA 10/2023 - 03/2010
6	teriflunomideIBA 10/2023 - 01/2016
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2023 - 10/2013
6	Vitamin D FDA LinkGeneric 09/2023 - 12/2012
6	Adenosine Triphosphate (ATP)IBA 01/2020 - 04/2010
5	Interferon-betaIBA 03/2024 - 09/2003
5	VaccinesIBA 01/2024 - 11/2021
5	SteroidsIBA 01/2023 - 09/2007
5	Messenger RNA (mRNA)IBA 06/2022 - 05/2006
4	AutoantibodiesIBA 01/2023 - 06/2012
4	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2007
4	CytokinesIBA 01/2019 - 01/2007
4	Fingolimod Hydrochloride (FTY720)FDA Link 10/2018 - 09/2015
4	FumaratesIBA 08/2015 - 07/2012
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2021
3	Complement System Proteins (Complement)IBA 01/2023 - 06/2012
3	Cladribine FDA LinkGeneric 01/2023 - 01/2020
3	Aquaporin 4IBA 01/2023 - 07/2015
3	Rituximab (Mabthera)FDA Link 11/2021 - 05/2008
3	InterferonsIBA 11/2021 - 01/2010
2	ofatumumab FDA Link 01/2024 - 10/2023
2	ocrelizumabIBA 01/2024 - 11/2021
2	Neutralizing AntibodiesIBA 08/2023 - 10/2022
2	Interferon beta-1a FDA Link 07/2023 - 12/2021
2	BNT162 VaccineIBA 05/2023 - 06/2022
2	TabletsIBA 01/2023 - 01/2022
2	nabiximols (Sativex)IBA 01/2022 - 05/2013
2	Therapeutic UsesIBA 01/2022 - 08/2014
2	Alemtuzumab (Campath)FDA Link 01/2022 - 12/2021
2	Infliximab (Remicade)FDA Link 08/2021 - 05/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021 - 05/2011
2	AlbuminsIBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 11/2014
2	RNA (Ribonucleic Acid)IBA 10/2020 - 03/2011
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 01/2019
2	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2009
2	Glatiramer Acetate (Copaxone)FDA Link 06/2017 - 11/2010
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 07/2015 - 03/2013
2	MicroRNAs (MicroRNA)IBA 05/2014 - 03/2011
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2014 - 01/2014
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2014 - 01/2011
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2014 - 01/2011
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2011 - 03/2008
1	insulin receptor-related receptor (IRR)IBA 01/2024

Therapy/Procedure

38	Therapeutics 03/2024 - 06/2004
10	Immunotherapy 01/2023 - 01/2012
5	Radiotherapy 10/2022 - 11/2008
3	Immunomodulation 07/2023 - 01/2009
3	Plasma Exchange 12/2019 - 09/2007
2	Activities of Daily Living (ADL) 03/2023 - 01/2023
2	Highly Active Antiretroviral Therapy (HAART) 02/2019 - 11/2014
2	Braces 10/2013 - 11/2012
2	Drug Therapy (Chemotherapy) 01/2011 - 11/2010